CYDY — Cytodyn Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Cytodyn, fiscal year end - May 31st, USD millions except per share, conversion factor applied.

	2022 May 31st	2023 May 31st	2024 May 31st	2025 May 31st	2026 May 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	4.23	2.54	3.11	11.9	11.9
Net Total Receivables	—	—	—	2	0
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28.4	10.8	10.8	17.9	13.9
Net Property, Plant And Equipment	0.609	0.4	0.264	0.13	0.073
Net Intangible Assets
Other Long Term Assets
Total Assets	29.2	11.3	11.1	18	14
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	123	120	84.2	70.5	53.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	124	121	128	114	124
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-94.4	-110	-117	-96	-110
Total Liabilities & Shareholders' Equity	29.2	11.3	11.1	18	14
Total Common Shares Outstanding
Total Preferred Shares Outstanding